Background Major depressive disorder (MDD) is a highly heterogenous disease, both in
terms of clinical profiles and pathobiological alterations. Recently, immunometabolic …

It is unknown whether indoles, metabolites of tryptophan that are derived entirely from bacterial
metabolism in the gut, are associated with symptoms of depression and anxiety. Serum …

The incidence of Alzheimer's disease (AD) increases with age and is becoming a significant
cause of worldwide morbidity and mortality. However, the metabolic perturbation behind the …

Background Altered metabolism of acylcarnitines – transporting fatty acids to mitochondria –
may link cellular energy dysfunction to depression. We examined the potential causal role …

In standard chemotherapy protocols, drugs are given at maximum tolerated doses (MTD) with
rest periods in between. In this paper, we briefly discuss the rationale behind this therapy …

Metabolome reflects the interplay of genome and exposome at molecular level and thus can
provide deep insights into the pathogenesis of a complex disease like major depression. To …

Many government organizations are now considering their transitions to clouds. However,
their concerns to known and unknown security risks in clouds are the major stumbling blocks …

Background Accumulating evidence suggests that Alzheimer’s disease (AD) patients display
metabolic dysfunction. Metabolomics is a powerful tool for studying metabolic pathways by …

Background Metabolic signatures that align with depression phenotypes could better
characterize the neurobiology of major depressive disorder (MDD) and its heterogeneity. We …

Background Primary and secondary bile acids and their glycine and taurine conjugated forms
are end products of cholesterol metabolism produced by human and gut microbiome co …